CELU Stock Analysis: Buy, Sell, or Hold?
CELU - Celularity Inc. Class A Common Stock
$0.70
0.02 (2.59%)
â˛
5d:
+10.29%
30d:
-6.3%
90d:
-22.79%
WAIT
LOW Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Sep 04, 2026
25d
Get Alerted When CELU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CELU is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CELU is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: CELU is currently trading at $0.70, which is considered slightly low relative to its 30-day fair value range of $0.67 to $0.78.
Technical Outlook: Technically, CELU is in a strong downtrend. Immediate support is located at $0.60, while resistance sits at $0.80.
Market Sentiment: CELU scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.50 (+256.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CELU is in a strong downtrend. Immediate support is located at $0.60, while resistance sits at $0.80.
Market Sentiment: CELU scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.50 (+256.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.67 -
$0.78
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding CELU? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (36/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 256.8% below Wall St target ($2.50)
- WARNING: Composite score 38/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.67 -
$0.78
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.60
Resistance Level
$0.80
Current Trend
Strong Downtrend
Technical data as of
Aug 7, 2026
Fundamental Context
Wall Street Target
$2.50
(+256.8%)
Revenue Growth (YoY)
-77.4%
Earnings Growth (YoY)
-61.3%
Share & Embed Analysis
Last updated: August 09, 2026 4:42 AM ET
Data refreshes hourly during market hours. Next update: 5:42 AM
Data refreshes hourly during market hours. Next update: 5:42 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CELU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 61 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$87 | 44 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 34 SELL |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$23 | 55 HOLD |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 45 HOLD |
Advanced CELU Option Strategies
Professional options setups generated by AI based on today's CELU price and gamma walls.
